Advertisement
Screener

ClearPoint Neuro, Inc. (CLPT) Form D

ClearPoint Neuro, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2026-02-05: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2025-11-20; Total offering amount $17,892,698.
  • 2019-05-29: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-05-17; Total offering amount $7,522,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2026-02-05Rule 506(b)Equity2025-11-20$17,892,698$17,892,698$046
2019-05-29Rule 506(b)Equity2019-05-17$7,522,000$7,522,000$017

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
NeuroPace Inc (NPCE)United States$0.480B-28.52
CARLSMED, INC. (CARL)United States$0.405B
Orthofix Medical Inc. (OFIX)$0.373B
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
CERUS CORP (CERS)United States$0.525B-86.40
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
Embecta Corp. (EMBC)United States$0.319B2.10